|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1201 Maryland Avenue SW |
Address2 | Suite 900 |
City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 6245-12
|
||||||||
|
6. House ID# 325050000
|
TYPE OF REPORT | 8. Year | 2012 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Brent DelMonte, Vice President for Federal Government Relations |
Date | 01/22/2013 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AGR
16. Specific lobbying issues
EPA Regulations on Agricultural Biotechnology
EPA Notice on PIP Data Requirements
USDA/APHIS Agricultural Biotechnology Regulations
S.3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
H.R. 6083: Federal Agriculture Reform and Risk Management Act of 2012 (Farm Bill)
Efficient Science-Based Review of Biotech Products
National Environmental Policy Act Requirements
Coexistence of Production Systems
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Genetically Engineered (GE) Animals
FDA Approval
Labeling
S. 1717: Prevention of Escapement of Genetically Altered Salmon in the United States Act of 2012
S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
Export Registrations for Products with Expired Patents
Labeling of Genetically Engineered (GE) Crops
U.S. Government Policy
Funding for the USDA (Office of General Counsel, Biotechnology Regulatory Services, National Institute of Food and Agriculture, APHIS, Trade Activities (Office of the Secretary & Food Safety Inspection Service), National Resources Conservation Service, Agriculture Research Service, Biofuels, Foreign Agriculture Service)
S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
Agricultural Biotechnology Regulatory Reform and Modernization
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
H.R. 6083: Federal Agriculture Reform and Risk Management Act of 2012 (Farm Bill)
Potential Regulation of New Genetic Modification Technologies
Foreign Agricultural Biotechnology Laws and Regulations
Low-Level Presence Foreign Government Policies
China Biotechnology Regulations
Asynchrony of International Approvals
Adventitious Presence (Low Level Presence)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), U.S. Trade Representative (USTR), White House Office, Office of Science & Technology Policy (OSTP), Environmental Protection Agency (EPA), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Tracey |
LaTurner |
|
|
|
Dana |
O'Brien |
|
|
|
Matthew |
O'Mara |
|
|
|
Brent |
Del Monte |
|
|
|
Derrick |
White |
|
|
|
Anna. |
Weinstein |
|
|
|
Tom |
DiLenge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ANI
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Genetically Engineered (GE) Animals
Labeling
FDA Approval
S. 1717: Prevention of Escapement of Genetically Altered Salmon in the United States Act of 2012
S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), U.S. Trade Representative (USTR), Agriculture - Dept of (USDA), Office of Science & Technology Policy (OSTP), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Dana |
O'Brien |
|
|
|
Derrick |
White |
|
|
|
Brent |
Del Monte |
|
|
|
Anna |
Weinstein |
|
|
|
Tracey |
LaTurner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013
Funding for the USDA (Office of General Counsel, Biotechnology Regulatory Services, National Institute of Food and Agriculture, APHIS, Trade Activities (Office of the Secretary & Food Safety Inspection Service), National Resources Conservation Service, Agriculture Research Service, Biofuels, Foreign Agriculture Service)
S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure)
S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
Funding for Bio-based Products
S.R. 2465/H.R. 5325: Department of Energy and Water and Related Agencies Appropriations Act for FY 2013
H.R. 6083: Federal Agriculture Reform and Risk Management Act of 2012 (Farm Bill)
S.3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Funding for Biofuels
S.R. 2465/H.R. 5325: Department of Energy and Water and Related Agencies Appropriations Act for FY 2013
H.R. 6083: Federal Agriculture Reform and Risk Management Act of 2012 (Farm Bill)
S.3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Funding for Biorefineries
S.R. 2465/H.R. 5325: Department of Energy and Water and Related Agencies Appropriations Act for FY 2013
H.R. 6083: Federal Agriculture Reform and Risk Management Act of 2012 (Farm Bill)
S.3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Funding for National Institutes of Health
National Center for Advancing Translational Sciences (NCATS)
S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013
Funding for Renewable Chemicals
S.R. 2465/H.R. 5325: Department of Energy and Water and Related Agencies Appropriations Act for FY 2013
H.R. 6083: Federal Agriculture Reform and Risk Management Act of 2012 (Farm Bill)
S.3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Sequestration of PDUFA Fees
Implementation of S. 365: Budget Control Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Agriculture - Dept of (USDA), Natl Institutes of Health (NIH), White House Office, Natl Security Council (NSC), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Tracey |
LaTurner |
|
|
|
Matt |
Carr |
|
|
|
Cathleen |
Enright |
|
|
|
Andrew |
Emmett |
|
|
|
Cartier |
Esham |
|
|
|
Brent |
DelMonte |
|
|
|
Dana |
O'Brien |
|
|
|
Sara |
Radcliffe |
|
|
|
Jeanne |
Haggerty |
|
|
|
David |
Edwards |
|
|
|
Kelly |
Cappio |
|
|
|
Phyllis |
Arthur |
|
|
|
Rina |
Singh |
|
|
|
Derrick |
White |
|
|
|
Sandi |
Dennis |
|
|
|
Catharine |
Harris |
|
|
|
Sarah |
Thornton Caswell |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CAW
16. Specific lobbying issues
Climate Change Benefits of Biofuels
Department of Defense Applications of Advanced Biofuels
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Dana |
O'Brien |
|
|
|
Matt |
Carr |
|
|
|
Brent |
Del Monte |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
Patent Reform
H.R. 6621: To correct and improve certain provisions of the Leahy-Smith America Invents Act
Intellectual Property International Enforcement
Compulsory Licensing
Patient Revocations
Indonesian Issues
Indian Issues
World Trade Organization Special 301 Submissions
International Trade Commission Reform
Rep. Devin Nunes Discussion Draft
TransPacific Partnership
Data and Intellectual Property Protections for Pharmaceuticals
Export Registrations for Products with Expired Patents
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR), State - Dept of (DOS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lila |
Feisee |
|
|
|
Hans |
Sauer |
|
|
|
Charles |
Fritts |
|
|
|
Brent |
Del Monte |
|
|
|
Tom |
DiLenge |
|
|
|
Joseph |
Damond |
|
|
|
Roy |
Zwahlen |
|
|
|
Anna |
Weinstein |
|
|
|
Jeanne |
Haggerty |
|
|
|
Matthew |
Schumaker |
|
|
|
Dana |
O'Brien |
|
|
|
Derrick |
White |
|
|
|
Cathleen |
Enright |
|
|
|
Matthew |
O'Mara |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
USDA/APHIS Agricultural Biotechnology Regulations
Efficient Science-Based Review of Biotech Products
National Environmental Policy Act Requirements
Coexistence of Production Systems
S.3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
H.R. 6083: Federal Agriculture Reform and Risk Management Act of 2012 (Farm Bill)
Genetically Engineered (GE) Animals
FDA Approval
Labeling
S. 1717: Prevention of Escapement of Genetically Altered Salmon in the United States Act of 2012
S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
Labeling of Genetically Engineered Crops
U.S. Government Policy
Drug Safety and Review
E-Pedigree and Anti-Counterfeiting (Sens. Michael Bennett/Richard Burr Discuss Draft)
Supply Chain Integrity
Implementation of P.L. No: 112-144: The Food and Drug Administration Safety and Innovation Act of 2012
Pharmacy Compounding
Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure)
S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), Office of Science & Technology Policy (OSTP), U.S. Trade Representative (USTR), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Andrew |
Emmett |
|
|
|
Anna |
Weinstein |
|
|
|
Sara |
Radcliffe |
|
|
|
Sandra |
Dennis |
|
|
|
Derrick |
White |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Matthew |
Schumaker |
|
|
|
Brent |
DelMonte |
|
|
|
Cartier |
Esham |
|
|
|
Tom |
DiLenge |
|
|
|
Jeanne |
Haggerty |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
Biorefineries
H.R. 6083: Federal Agriculture Reform and Risk Management Act of 2012 (Farm Bill)
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Renewable Fuels Standard
Regulatory Oversight
Implementation of P.L. No: 112-140: Energy Independence and Security Act
Super Storm Sandy Emergency Supplemental Appropriations (Discussion Draft)
Biofuels
Funding
Department of Defense Applications of Advanced Biofuels
Production Tax Credit Extension
Production Tax Credit Modification for Algae-based Biofuels
Investment Tax Credit Options
Next Generation Incentives
Economic Growth Impact/Potential of Advanced Biofuels
S.3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
H.R. 6083: Federal Agriculture Reform and Risk Management Act of 2012 (Farm Bill)
S.R. 2465/H.R. 5325: Department of Energy and Water and Related Agencies Appropriations Act for FY 2013
S. 3521: Family and Business Tax Cut Certainty Act of 2012
H.R. 5856: Department of Defense Appropriations Act for FY 2013
H.R. 4310/S.3254: National Defense Authorization Act for FY 2013
American Taxpayer Relief Act (Discussion Draft)
Bio-based Products
Tax Credit
H.R. 6083: Federal Agriculture Reform and Risk Management Act of 2012 (Farm Bill)
S.3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
H.R. 4953/S.3491: Qualifying Renewable Chemical Production Tax Credit Act of 2012
American Taxpayer Relief Act (Discussion Draft)
Renewable Chemicals
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
H.R. 6083: Federal Agriculture Reform and Risk Management Act of 2012 (Farm Bill)
H.R. 4953/S.3491: Qualifying Renewable Chemical Production Tax Credit Act of 2012
American Taxpayer Relief Act (Discussion Draft)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Environmental Protection Agency (EPA), Agriculture - Dept of (USDA),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matt |
Carr |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Charles |
Fritts |
|
|
|
Rina |
Singh |
|
|
|
Brent |
Del Monte |
|
|
|
Sarah |
Thornton Caswell |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOO
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Genetically Engineered (GE) Animals
FDA Approval
Labeling
S. 1717: Prevention of Escapement of Genetically Altered Salmon in the United States Act of 2012
S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
Labeling of Genetically Engineered Crops
U.S. Government Policy
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Food & Drug Administration (FDA), U.S. Trade Representative (USTR), Office of Science & Technology Policy (OSTP), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cathleen |
Enright |
|
|
|
David |
Edwards |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Brent |
Del Monte |
|
|
|
Derrick |
White |
|
|
|
Anna |
Weinstein |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FUE
16. Specific lobbying issues
Renewable Fuels Standard
Regulatory Oversight
Implementation of P.L. No: 112-140: Energy Independence and Security Act
Super Storm Sandy Emergency Supplemental Appropriations (Discussion Draft)
Biofuels
Funding
Department of Defense Applications of Advanced Biofuels
Production Tax Credit Extension
Production Tax Credit Modification for Algae-based Biofuels
Investment Tax Credit Options
Next Generation Incentives
Economic Growth Impact/Potential of Advanced Biofuels
S.3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
H.R. 6083: Federal Agriculture Reform and Risk Management Act of 2012 (Farm Bill)
S.R. 2465/H.R. 5325: Department of Energy and Water and Related Agencies Appropriations Act for FY 2013
S. 3521: Family and Business Tax Cut Certainty Act of 2012
H.R. 5856: Department of Defense Appropriations Act for FY 2013
H.R. 4310/S.3254: National Defense Authorization Act for FY 2013
American Taxpayer Relief Act (Discussion Draft)
Biorefineries
H.R. 6083: Federal Agriculture Reform and Risk Management Act of 2012 (Farm Bill)
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
Bio-based Products
Tax Credit
H.R. 6083: Federal Agriculture Reform and Risk Management Act of 2012 (Farm Bill)
S.3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
H.R. 4953/S.3491: Qualifying Renewable Chemical Production Tax Credit Act of 2012
American Taxpayer Relief Act (Discussion Draft)
Renewable Chemicals
S. 3240: Agriculture Reform, Food, and Jobs Act of 2012 (Farm Bill)
H.R. 6083: Federal Agriculture Reform and Risk Management Act of 2012 (Farm Bill)
H.R. 4953/S.3491: Qualifying Renewable Chemical Production Tax Credit Act of 2012
American Taxpayer Relief Act (Discussion Draft)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matt |
Carr |
|
|
|
Dana |
O'Brien |
|
|
|
Tracey |
LaTurner |
|
|
|
Charles |
Fritts |
|
|
|
Rina |
Singh |
|
|
|
Brent |
DelMonte |
|
|
|
Sarah |
Thornton Caswell |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Funding for National Institutes of Health
National Center for Advancing Translational Sciences (NCATS)
S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013
Vaccine Access/Financing
Federal Response to the Rising Rates of Autism
Tax for Seasonal Influenza Funding
H.R. 6687/S.3716: A Bill to Amend the Internal Revenue Code of 1986 to Include Vaccines against Seasonal Influenza within the Definition of Taxable Vaccines
340B Drug Pricing Program
HRSA Implementation of Program Changes
Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act of 2010
Average Manufacturer Price Calculations
Therapeutic Discovery Project Tax Credit
S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to
Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program
Drug Safety and Review
E-Pedigree and Anti-Counterfeiting (Sens. Michael Bennett/Richard Burr Discuss Draft)
Supply Chain Integrity
Implementation of P.L. No: 112-144: The Food and Drug Administration Safety and Innovation Act of 2012
Pharmacy Compounding
Funding for FDA (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Medical Countermeasures, Center for Veterinary Medicine, Scientific Infrastructure)
S.R. 2375/H.R. 5973: Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2013
Independent Payment Advisory Board
H.R. 5: Protecting Access to Healthcare Act of 2011
Implementation of P.L. No: 111-148: Patient Protection and Affordable Care Act of 2010
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development, and Procurement
S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013
Biodefense Research, Development, and Procurement
S 1855/H.R. 2405: Pandemic and All Hazards Preparedness Act Reauthorization of 2011
HHS Countermeasures Review
TransPacific Partnership
Data and Intellectual Property Protections for Pharmaceuticals
Regulatory Transparency
Reimbursement for Innovative Products
Medicare Part B Physician-Administered Products
Medicare Part D Prescription Drug Program
Sequestration of PDUFA Fees
Implementation of P.L. No: 112-25: Budget Control Act
Medicaid Rebates
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Catharine |
Harris |
|
|
|
Roy |
Zwahlen |
|
|
|
Sandra |
Dennis |
|
|
|
Andrew |
Emmett |
|
|
|
Matthew |
Schumaker |
|
|
|
Jeanne |
Haggerty |
|
|
|
Sara |
Radcliffe |
|
|
|
Phyllis |
Arthur |
|
|
|
Anna |
Weinstein |
|
|
|
Derrick |
White |
|
|
|
Cartier |
Esham |
|
|
|
Lila |
Feisee |
|
|
|
Tom |
DiLenge |
|
|
|
Tracey |
LaTurner |
|
|
|
Laurel |
Todd |
|
|
|
Brent |
Del Monte |
|
|
|
Alan |
Eisenberg |
|
|
|
Charles |
Fritts |
|
|
|
Alyson |
Pusey |
|
|
|
Kelly |
Cappio |
|
|
|
Joseph |
Damond |
|
|
|
Charles |
Crain |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development, and Procurement
S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013
Biodefense Research, Development, and Procurement (Non-Funding Issues)
S. 1855/H.R. 2405: Pandemic and All Hazards Preparedness Act Reauthorization of 2011
HHS Countermeasures Review
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Security Council (NSC), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Derrick |
White |
|
|
|
Anna |
Weinstein |
|
|
|
Phyllis |
Arthur |
|
|
|
Matthew |
Schumaker |
|
|
|
Tracey |
LaTurner |
|
|
|
Jeanne |
Haggerty |
|
|
|
Brent |
Del Monte |
|
|
|
Sara |
Radcliffe |
|
|
|
Kelly |
Cappio |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Biodefense Research, Development, and Procurement (Non-Funding Issues)
HHS Countermeasures Review
S. 1855/H.R. 2405: Pandemic and All Hazards Preparedness Act Reauthorization of 2011
Funding for National Institutes of Health
National Center for Advancing Translational Sciences (NCATS)
S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013
Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement
S.R. 3295: Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2013
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Natl Institutes of Health (NIH), Natl Security Council (NSC), Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sara |
Radcliffe |
|
|
|
Jeanne |
Haggerty |
|
|
|
Tracey |
LaTurner |
|
|
|
Anna |
Weinstein |
|
|
|
Phyllis |
Arthur |
|
|
|
Cartier |
Esham |
|
|
|
Kelly |
Cappio |
|
|
|
Brent |
Del Monte |
|
|
|
Derrick |
White |
|
|
|
Matthew |
Schumaker |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Average Manufacturer Price Calculations
Medicaid Rebates
Reimbursement for Innovative Products
Medicare Part B Physician-Administered Products
Medicare Part D Prescription Drug Program
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE,
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Alyson |
Pusey |
|
|
|
Laurel |
Todd |
|
|
|
Matthew |
Schumaker |
|
|
|
Brent |
Del Monte |
|
|
|
Jeanne |
Haggerty |
|
|
|
Anna |
Weinstein |
|
|
|
Derrick |
White |
|
|
|
Sara |
Radcliffe |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
Small Business Innovation Research (SBIR) Program
Rulemaking
Research & Development Tax Credit Extension
Innovative Research and Competitiveness Act (Senator Carper Discussion Draft)
Startup Innovation Credit Act (Senator Coons Discussion Draft)
American Taxpayer Relief Act (Discussion Draft)
S.3521: Family and Business Tax Cut Certainty Act of 2012
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Small Business Adminstration (SBA),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cartier |
Esham |
|
|
|
Charles |
Fritts |
|
|
|
Brent |
Del Monte |
|
|
|
Alan |
Eisenberg |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SMB
16. Specific lobbying issues
Small Business Innovation Research (SBIR) Program
Rulemaking
Market Structure Reform for Small Companies
Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions
H.R. 6161: Fostering Innovation Act of 2012
Therapeutic Discovery Project Tax Credit
S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to
Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program
Capital Formation Investment Incentives
H.R. 6599/S.3595: High Technology Small Business Research Incentives Act of 2012
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Small Business Adminstration (SBA), Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cartier |
Esham |
|
|
|
Charles |
Fritts |
|
|
|
Alan |
Eisenberg |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Charles |
Crain |
|
|
|
Brent |
Del Monte |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Bio-based Products
Tax Credit
H.R. 4953/S.3491: Qualifying Renewable Chemical Production Tax Credit Act of 2012
Vaccine Access/Financing
Tax for Seasonal Influenza Funding
H.R. 6687/S.3716: A Bill to Amend the Internal Revenue Code of 1986 to Include Vaccines against Seasonal Influenza within the Definition of Taxable Vaccines
Tax Reform
Therapeutic Discovery Project Tax Credit
S.3232: A Bill to Amend the Internal Revenue Code of 1986 and the Patient Protection and Affordable Care Act to
Extend, Expand, and Improve the Qualifying Therapeutic Discovery Project Program
Capital Formation Investment Incentives
H.R. 6599/S.3595: High Technology Small Business Research Incentives Act of 2012
Research & Development Tax Credit Extension
Innovative Research and Competitiveness Act (Senator Carper Discussion Draft)
Startup Innovation Credit Act (Senator Coons Discussion Draft)
American Taxpayer Relief Act (Discussion Draft)
S.3521: Family and Business Tax Cut Certainty Act of 2012
Biofuels
Production Tax Credit Modification for Algae-based Biofuels
Production Tax Credit Extension
Investment Tax Credit Options
S. 3521: Family and Business Tax Cut Certainty Act of 2012
American Taxpayer Relief Act (Discussion Draft)
Renewable Chemicals
H.R. 4953/S.3491: Qualifying Renewable Chemical Production Tax Credit Act of 2012
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Treasury - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Matt |
Carr |
|
|
|
Shelly |
Mui-Lipnik |
|
|
|
Sarah |
Thornton Caswell |
|
|
|
Charles |
Crain |
|
|
|
Rina |
Singh |
|
|
|
Charles |
Fritts |
|
|
|
Kelly |
Cappio |
|
|
|
Phyllis |
Arthur |
|
|
|
Matt |
Schumaker |
|
|
|
Catharine |
Harris |
|
|
|
Brent |
Del Monte |
|
|
|
Alan |
Eisenberg |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRD
16. Specific lobbying issues
Livestock Cloning/Product Labeling
Discussions with EU on Animal Cloning
Export Registrations for Products with Expired Patents
World Trade Organization Special 301 Submissions
International Trade Commission Reform
Rep. Devin Nunes Discussion Draft
Foreign Agricultural Biotechnology Laws and Regulations
Low-Level Presence Foreign Government Policies
China Biotechnology Regulations
Asynchrony of International Approvals
TransPacific Partnership
Data and Intellectual Property Protections for Pharmaceuticals
Regulatory Transparency
Intellectual Property International Enforcement
Compulsory Licensing
Patient Revocations
Indonesian Issues
Indian Issues
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, U.S. Trade Representative (USTR), Agriculture - Dept of (USDA), State - Dept of (DOS), Office of Science & Technology Policy (OSTP),
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charles |
Fritts |
|
|
|
David |
Edwards |
|
|
|
Dana |
O'Brien |
|
|
|
Lila |
Feisee |
|
|
|
Tom |
DiLenge |
|
|
|
Jeanne |
Haggerty |
|
|
|
Roy |
Zwahlen |
|
|
|
Matthew |
O'Mara |
|
|
|
Cathleen |
Enright |
|
|
|
Brent |
Del Monte |
|
|
|
Joseph |
Damond |
|
|
|
. |
. |
|
|
|
. |
. |
|
|
|
. |
. |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address: BIO maintains a list of all of its members on its website at http://bio.org/membership/index.asp
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |